The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis
Vágfalvy, I.; Fehér, L.
Orvosi Hetilap 111(12): 685-687
1970
ISSN/ISBN: 0030-6002 PMID: 5436299 Document Number: 21424
Document emailed within 1 workday
Related Documents
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Gränzer, W.; Eichinger, H. 1982: Inhibition of isoprenaline-induced tachycardia in calves with the beta-receptor blockader carazolol Berliner und Munchener Tierarztliche Wochenschrift 95(3): 47-49
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Rabast, U.; Kasper, H.; Schönborn, J.; Knechtel, B. 1977: Blood glucose concentration and insulin activity in serum after administration of the beta receptor blockader nifenalol-HC1 (INPEA). Studies in metabolically healthy people and diabetics Therapie der Gegenwart 116(6): 1162-1174
Zdichynec, B. 1977: Treatment of supraventricular arrhythmias using the beta-blockader Visken Zeitschrift für Arztliche Fortbildung 71(10): 478
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Zonis, B.Ia.; Brin, V.B. 1979: Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane Terapevticheskii Arkhiv 51(11): 28-30
Hoppe, H.J.; Krüger, K.; Rosenthal, J.; Schrey, A.; Eberhardt, R. 1980: Beta blockader treatment in ambulatory hypertension care. a multicentric long-term study ZFA. Zeitschrift für Allgemeinmedizin 56(7): 496-504
Marchetti, G.; Merlo, L.; Noseda, V. 1973: Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601 Bollettino Della Societa Italiana di Cardiologia 18(7): 672-675
Shmidt, I.; Khomut, V.; Monike, V.; Bakh, K.; Fliugel', K. 1985: Central and peripheral hemodynamics during combined treatment of arterial hypertension with calcium antagonist nifedipine and beta-adrenergic blockader talinolol Kardiologiia 25(6): 110-111
Zilenovski, A.M.; Freire, C.A.; Iverson, M.T. 1984: Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. a multicenter study Arquivos Brasileiros de Cardiologia 42(6): 435-441
Meister, W. 1983: A beta blockader for every postinfarct patient? Münchener Medizinische Wochenschrift 125(46): 1055-1056
Schmidt, E.; Bruch H-P 1978: 1st experiences with the alpha-receptor blockader phentolamine in achalasia Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 49(1): 22-24
Rudloff, P.R.; Bostedt, H. 1984: Effect of the beta blockader carazolol (Suacron) on parturition in sows Tierarztliche Praxis 12(4): 443-449
Silverii, A.; Bonolis, G.; Tomassini, P.K.; Campa, P.P. 1972: Effect of a beta-blockader on postural arterial reflectivity in normal subjects Bollettino Della Societa Italiana di Cardiologia 17(8): 503-508